A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis

S. Clark, E. Tindall, R. M. Bennett

Research output: Contribution to journalArticlepeer-review

177 Scopus citations

Abstract

Twenty patients with a diagnosis of fibrositis were entered into a double blinded crossover study to compare the effects of prednisone versus placebo. Each patient was randomly assigned to either prednisone 15 mg/day or placebo for 14 days of therapy and then therapy was switched for a further 14 days. The following measurements were assessed at baseline, end of Week 2 and end of Week 4: analogue scores for pain, sleep disturbance, morning stiffness and fatiguability, and dolorimetry readings of pain tolerance over 14 representative tender joints. Overall there was no improvement while taking prednisone, indeed most measured variables showed a trend towards deterioration with this therapy.

Original languageEnglish (US)
Pages (from-to)980-983
Number of pages4
JournalJournal of Rheumatology
Volume12
Issue number5
StatePublished - 1985
Externally publishedYes

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis'. Together they form a unique fingerprint.

Cite this